Home/Filings/4/0001746473-25-000001
4//SEC Filing

Ouimette Mike 4

Accession 0001746473-25-000001

CIK 0001746473other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:55 PM ET

Size

7.7 KB

Accession

0001746473-25-000001

Insider Transaction Report

Form 4
Period: 2025-01-17
Ouimette Mike
General Counsel & Corp. Sec'y
Transactions
  • Sale

    Common Stock

    2025-01-17$11.20/sh13,270$148,63980,774 total
  • Sale

    Common Stock

    2025-01-22$10.99/sh10,230$112,46270,544 total
Footnotes (3)
  • [F1]Represents a nondiscretionary sale by the plan on behalf of the Reporting Person in a manner intended to satisfy the requirements of Rule 10b5-1. The sale price of the Reporting Person's shares represents the weighted average of all shares sold by a broker at prices ranging from $11.03 to $11.695, inclusive, on January 17, 2025 and January 21, 2025 on behalf of a group of employees of the Issuer, including the Reporting Person, to satisfy the payment of withholding tax liability in connection with the vesting of previously granted restricted stock units. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (1) to this Form 4.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $10.88 to $11.21, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001822619

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:55 PM ET
Size
7.7 KB